ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2254

The Urge for Mobile Apps in Rheumatology – a German Patient Perspective

Johannes Knitza1, Christina Raab 1, Antonia Lambrecht 1, David Simon 2, Melanie Hagen 1, Sara Bayat 1, Georg Schett 3, Arnd Kleyer 1 and Axel Hueber 4, 1Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany, Erlangen, Germany, 2Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Bayern, Germany, 3Department of Internal Medicine 3, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany, 4Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany; Sektion Rheumatologie, Sozialstiftung Bamberg, Klinikum Bamberg, Bamberg, Germany, Erlangen, Germany

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Clinical research methods, MHealth, patient preferences, social media and website

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Session Title: Patient Outcomes, Preferences, & Attitudes Poster II: Patient Preferences, Beliefs, & Experiences

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Mobile health applications have the potential of saving costs, empowering patients and improving treatment outcomes. Furthermore, the use of medical apps in routine care is increasing among rheumatologists[1]. In order to turn digitalization and all its benefits into practice it is crucial to include the main stakeholders. We therefore wanted to explore the needs and attitudes of patients with rheumatic diseases concerning mobile apps.

Methods: Between December 2018 and January 2019, 224 consecutive patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis were seen at one rheumatology outpatients clinic and asked to complete a paper-based survey. This survey evaluated the individual mobile app experiences, preferences and attitudes. This study was approved by the Ethics committee (No. 418-18B) and all patients consented to the study.

Results: Patient demographics are displayed in Table 1. 198 patients (90%) regularly used a smartphone, 103 patients (46%) regularly used social media. 144 (65%) patients believed that using medical apps could be beneficial for their health. Only 9 patients (4%) were currently using medical apps and only 24 patients (11%) stated that they knew useful rheumatology websites / mobile apps. 211 patients (96%) would agree to share their mobile app data for research purposes if data was transferred by a secure and anonymized / pseudonymized method. 166 patients (76%) would welcome official mobile app recommendations from the national rheumatology society. Only 33% would not consent to future data entry (Figure 1), whereas average time for entry should not exceed more than 5 minutes.  The most popular three app features desired were information about the disease, medication and sports and nutrition (Figure 2).

Conclusion: Most patients possessed smartphones and believed that using medical apps could be beneficial for their health. They were also willing to share data for research purposes. However only a small minority were currently using medical apps or knew useful apps. Patients stated that they would welcome app recommendations and information provided by apps. We could successfully identify unmet needs and patient priorities to accelerate and guide the way of mobile apps into routine rheumatology care.

References: 1. Knitza, J. et al. [Use of medical apps and online platforms among German rheumatologists : Results of the 2016 and 2018 DGRh conference surveys and research conducted by rheumadocs].Z Rheumatol, 2018.


Disclosure: J. Knitza, None; C. Raab, None; A. Lambrecht, None; D. Simon, None; M. Hagen, None; S. Bayat, None; G. Schett, AbbVie, BMS, Celgene, Janssen, Lilly, Novartis, Pfizer, 8, AbbVie, BMS, Celgene, Janssen, Lilly, Novartis, UCB, 5, BMS, Celgene, GSK, Lilly, Novartis, 2; A. Kleyer, None; A. Hueber, None.

To cite this abstract in AMA style:

Knitza J, Raab C, Lambrecht A, Simon D, Hagen M, Bayat S, Schett G, Kleyer A, Hueber A. The Urge for Mobile Apps in Rheumatology – a German Patient Perspective [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-urge-for-mobile-apps-in-rheumatology-a-german-patient-perspective/. Accessed March 27, 2023.
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-urge-for-mobile-apps-in-rheumatology-a-german-patient-perspective/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences